Can vitamin B12 (cobalamin) deficiency increase the risk of ischemic stroke?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 3, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Yes, Low B12 Can Contribute to Stroke Risk

Low vitamin B12 levels significantly increase the risk of ischemic stroke through elevated homocysteine levels, and B12 deficiency is a frequently missed, modifiable risk factor that should be screened for and corrected in all patients at risk for or recovering from stroke. 1

The Evidence Linking B12 Deficiency to Stroke

The 2022 guideline published in Stroke provides compelling evidence that B12 deficiency increases stroke risk through the homocysteine pathway 1. The mechanism is straightforward: B12 is essential for converting homocysteine to methionine, and when B12 is deficient, homocysteine accumulates to toxic levels that damage blood vessels and promote atherosclerosis.

Key Clinical Data:

  • B vitamins including B12 reduced ischemic stroke by 43% in randomized controlled trials, confirmed across multiple meta-analyses 1
  • Among stroke patients, 17.3% had biochemical or metabolic B12 deficiency in one stroke prevention clinic cohort 1
  • In a larger study of 4,055 stroke patients, 8.3% had biochemical B12 deficiency and 10.6% had metabolic B12 deficiency 1
  • In patients over age 80, metabolic B12 deficiency was present in 18.1% 1

Recent research confirms these findings: stroke patients had significantly lower B12 levels (194.24 ± 91.11 pmol/L) compared to controls (271.13 ± 91.19 pmol/L), and lower B12 correlated with worse stroke severity and poorer functional outcomes 2.

Understanding Metabolic vs. Biochemical B12 Deficiency

A critical pitfall: A "normal" serum B12 does not rule out B12 deficiency. 1

  • Biochemical deficiency: Serum B12 below the reference range
  • Metabolic deficiency: Serum B12 below 258 pmol/L (or <300 pg/mL) with elevated homocysteine or methylmalonic acid 1, 3

Metabolic B12 deficiency is frequently missed because clinicians accept a B12 level in the "normal range" as adequate. This is a major missed opportunity for stroke prevention 1.

Who Is at Highest Risk?

B12 deficiency is particularly common in:

  • Older adults (especially >80 years) due to decreased absorption 1
  • Vegetarians and vegans (dietary insufficiency) 1
  • Patients with renal impairment (GFR <50 mL/min) 1
  • Patients on metformin or proton pump inhibitors (impaired absorption)
  • Geographic populations: Very high rates in India (32% in adolescents), Pakistan (58.3% of stroke patients), and China (16.7% with severe hyperhomocysteinemia) 1

Clinical Recommendations

All patients with ischemic stroke or at high risk should have serum B12 and total homocysteine (tHcy) measured and treated if abnormal. 1

Screening Thresholds:

  • Measure serum B12, total homocysteine, and consider methylmalonic acid if B12 is borderline
  • Treat if B12 <258 pmol/L (<300 pg/mL) 1, 3
  • Treat if homocysteine ≥14-15 µmol/L 1
  • Target homocysteine <10 µmol/L for optimal stroke prevention 1

Treatment Approach:

Use methylcobalamin or hydroxycobalamin instead of cyanocobalamin 1. This is an important caveat from the guidelines, as cyanocobalamin may be less effective or even harmful in certain populations, particularly those with renal impairment.

The evidence supports B vitamin supplementation as a Class 2a (moderate) recommendation for stroke risk reduction 1.

The Homocysteine Connection

B12 deficiency increases stroke risk primarily through hyperhomocysteinemia 1, 4, 5. Elevated homocysteine:

  • Damages vascular endothelium
  • Promotes atherosclerosis
  • Increases thrombotic risk
  • Contributes to large-artery atherosclerosis stroke 3

The optimal cut-off for B12 to predict large-artery atherosclerosis stroke was 305-308 pg/mL, with lower levels significantly increasing risk 3.

Impact on Stroke Outcomes

Beyond increasing stroke risk, B12 deficiency worsens stroke outcomes 2, 6:

  • Higher stroke severity (NIHSS scores)
  • Worse functional outcomes (modified Rankin Scale)
  • Increased mortality
  • Impaired motor function recovery
  • Changes in neuronal survival and metabolism

The mechanisms include altered myelination, disrupted nerve tissue metabolism and transmission, and increased neuroinflammation 4, 5, 6, 7.

Bottom Line for Clinical Practice

B12 deficiency is an inexpensive, easily correctable risk factor that is frequently overlooked. The convergence of guideline recommendations and recent research strongly supports routine screening in stroke patients and high-risk populations, with aggressive treatment of deficiency using appropriate B12 formulations (methylcobalamin or hydroxycobalamin) to achieve target homocysteine levels below 10 µmol/L.

Related Questions

What is the impact of iron deficiency and vitamin B12 deficiency on outcomes in stroke patients with anemia, and how should these deficiencies be managed?
What is the role of vitamin B12 in stroke recovery and prevention of future vascular events?
What is the role of iron deficiency anemia and vitamin B12 deficiency in stroke risk, and how should each be treated?
What is the appropriate vitamin B12 replacement regimen and dosage for a 36-year-old woman with a recent cerebellar, occipital, and frontal lobe stroke and documented vitamin B12 deficiency with elevated serum homocysteine?
What is the recommended continuation of Vitamin B12 treatment for a post-stroke patient with a current Vitamin B12 level of 292 pg/mL, who received one cyanocobalamin (Vitamin B12) injection 2 months ago?
How long does it take for abdominal pain to subside after taking otilonium bromide for irritable bowel syndrome?
What is the recommended dose of Fraxiparina (nadroparin) for venous thrombo‑embolism prophylaxis and treatment in an adult patient without severe renal impairment?
What are the criteria and indications for knee intra‑articular steroid injections, and should plain radiographs and a course of physical therapy be tried first?
What symptom causes vertigo when riding an elevator or looking down from a tall building?
Is Florastore (Saccharomyces boulardii) safe for someone who is lactose intolerant or cannot take lactase supplements?
When treating chronic psychiatric disorders such as schizophrenia or bipolar disorder, should quetiapine (Seroquel) be prescribed as a scheduled (routine) daily dose rather than an as‑needed (prn) dose?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.